NCT03029611.

Trial name or title	A phase II study of concurrent IGFBP‐2 vaccination and neoadjuvant chemotherapy to increase the rate of pathologic complete response at the time of cytoreductive surgery
Methods	Uncontrolled phase II
Participants	38 participants with fallopian tube cancer, ovarian cancer, or primary peritoneal cancer
Interventions	Intravenous paclitaxel and carboplatin, intradermal IGFBP‐2 vaccine
Outcomes	Clinical response Immune response
Starting date	April 2017
Contact information
Notes	Recruiting, May 2018